Pfizer Begins Study Testing Omicron Vaccine in People

[Yo_Mama_Been_Loggin]

Pfizer Inc. and BioNTech SE have started a trial evaluating an adapted version of their Covid-19 vaccine that targets the Omicron variant of the coronavirus.

The drugmakers said Tuesday they began enrolling adults ages 18 to 55 in the U.S. and South Africa to examine the safety, tolerability and immune response generated by the vaccine if it is given either as a primary series or as a booster dose.

One subject has already received the shot, Pfizer said.

Initial study results are expected in the first half of the year, Pfizer said. The drugmaker could ask U.S. regulators for authorization and begin distribution in March, should the Omicron-targeted shot prove to work safely, Chief Executive Albert Bourla has said.

https://www.msn.com/en-us/health/medical/pfizer-begins-study-testing-omicron-vaccine-in-people/ar-AAT7Csx

[Salviati]

1. Excellent. Omicron seems to be so successful at spreading...

... that it seems likely that any subsequent variants will be derived from it, it's just a numbers game and omicron seems to be dominating the stats right now. It will be good to have a vaccine targeting it specifically, as it seems to me that will be more effective against future mutations.